Innovating Works

InDx CMC Implant

Financiado
The InDx CMC Implant. A new treatment for thumb base joint arthritis.
The InDx CMC Implant is for the treatment of thumb base joint arthritis. It is the first evidence-based, surgeon-led innovation, implant solution for this major clinical problem. The potential market is estimated at over €700M per... The InDx CMC Implant is for the treatment of thumb base joint arthritis. It is the first evidence-based, surgeon-led innovation, implant solution for this major clinical problem. The potential market is estimated at over €700M per year. The implant meets a major unmet clinical need for an ageing EU population. The implant re-creates the natural joint biomechanics to give a more reliable and clinically superior outcome for patients. This disruptive technology can change the treatment landscape for this condition. The implant provides an exciting new treatment option for an under-served population. It has been shown to eliminate pain and restore full joint mobility. The InDx Implant is smarter, safer, and simpler to insert than any current treatment options. The InDx Implant is patented, with a clear pathway to regulatory clearance in the EU and US. The company is led by a physician-innovator and is supported by medical device industry veterans and world-leading hand surgeons. ver más
30/04/2024
4M€
Duración del proyecto: 17 meses Fecha Inicio: 2022-11-16
Fecha Fin: 2024-04-30

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-04-30
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 4M€
Líder del proyecto
LOCI ORTHOPAEDICS LIMITED No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5